Dubai: The Middle East Pharmacoeconomics and Drug Policy Summit (MEPDPS) 2023 concluded recently, bringing together a diverse array of industry leaders and experts in Dubai. The two-day event focused on key themes such as Pharmacoeconomics, value-based healthcare, evidence-based medication, and Health Technology Assessment (HTA).
The summit served as a strategic meeting point for regulatory authorities, Pharmacoeconomics, health economists, health technology assessment specialists, payers, healthcare providers, and representatives from the pharmaceutical industry. The discussions centered on enhancing decision-making processes, improving access to life-saving medications, and ensuring the affordability of essential drugs.
MEPDPS 2023 featured prominent speakers and thought leaders, including Ahmed Al Jedai, Founding President of the Saudi Society of Clinical Pharmacy (SSCP), who chaired the summit. Attendees gained valuable insights into future opportunities and challenges within the healthcare and research economy of GCC countries.
With its focus on value assessment, cost-effective healthcare solutions, and evidence-based practices, the summit aimed to foster collaboration and pave the way for advancements in the healthcare industry across the Middle East region.
MEPDPS 2023 offered a platform for exchanging ideas, exploring the latest research, and driving innovation in healthcare delivery. This gathering of experts will undoubtedly contribute to the enhancement of healthcare decision-making, leading to improved patient outcomes and increased accessibility to essential medicines.
